Skip to main content
Log in

Mortality of patients with parkinson's disease treated with levodopa

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with a decarboxylase inhibitor during 1969–1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a ratio of actual to expected deaths of 1.85. The excess mortality was accounted for by patients with a severe disease at entry and especially, by the less favorable effect of levodopa treatment than in the living patients. In comparison with the prelevodopa era, the reduction of mortality and the increase of life expectancy of patients with Parkinson's disease during levodopa treatment possibly reflect the decrease of the early mortality due to Parkinson's disease.

Zusammenfassung

Die Auswirkung der Levodopa-Behandlung auf die Mortalität von Parkinson-Patienten wurde anhand einer Serie von 349 Fällen untersucht, welche in den Jahren 1969–1975 einerseits mit L-Dopa, andererseits mit L-Dopa zusammen mit Decarboxylasehemmern behandelt wurden. Während der Beobachtungsperiode verstarben 61 Patienten. Die erwartete Mortalität hätte 32,99 betragen müssen, was eine Relation von tatsächlicher zu erwarteter Mortalität von 1,85 ergibt. Für die höhere Mortalität waren Fälle verantwortlich mit schweren Krankheitserscheinungen bei Beginn der Therapie und im besondern auch mit einem geringeren Effekt der L-Dopa-Therapie als bei den überlebenden Patienten. Verglichen mit den Beobachtungen vor Einführung der L-Dopa-Therapie beruht wohl die Verminderung der Mortalität und die erhöhte Lebenserwartung von Parkinson-Patienten unter L-Dopa auf der Abnahme der Frühtodesfälle durch die Parkinson'sche Krankheit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barbeau, A.: Six years high-level levodopa therapy in severely akinetic parkinsonian patients. Arch. Neurol. 33, 333–338 (1976)

    Google Scholar 

  2. Birkmayer, W., Ambrozi, L., Neumayer, E., Riederer, P.: Longevity in Parkinson's disease treated with L-DOPA. Clin. Neurol. Neurosurg. 77, 15–19 (1974)

    Google Scholar 

  3. Cotzias, G. C., van Woert, M. H., Schiffer, I. M.: Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276, 374–379 (1967)

    Google Scholar 

  4. Diamond, S. G., Markham, Ch. H.: Present mortality in Parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths. J. Neural. Transm. 38, 259–269 (1976)

    Google Scholar 

  5. Hoehn, M. M., Yahr, M. D.: Parkinsonism: onset, progression and mortality. Neurology 17, 427–442 (1967)

    Google Scholar 

  6. Kurland, L. T.: Epidemiology: incidence, geographic distribution and genetic considerations. Pathogenesis and treatment of Parkinsonism. Springfield, Ill.: Thomas 1958

    Google Scholar 

  7. Markham, Ch. H., Treciokas, L. J., Diamond, S. G.: Parkinson's disease and levodopa — a five year follow up and review. West. J. Med. 121, 188–206 (1974)

    Google Scholar 

  8. Marttila, R. J.: Calculation of expected deaths in mortality studies of Parkinson's disease. J. Neural. Transm. 40, 177–178 (1977)

    Google Scholar 

  9. Rinne, U. K., Sonninen, V., Siirtola, T.: L-Dopa treatment in Parkinson's disease. Europ. Neurol. 4, 348–369 (1970)

    Google Scholar 

  10. Rinne, U. K., Sonninen, V., Siirtola, T.: Treatment of Parkinson's disease with L-Dopa and a decarboxylase inhibitor. J. Neurol. 202, 1–20 (1972)

    Google Scholar 

  11. Rinne, U. K., Sonninen, V., Siirtola, T.: Long-term treatment of Parkinsonism with L-Dopa and decarboxylase inhibitor. A clinical and biochemical approach. Advances in Parkinsonism, pp. 555–565. Basle: Editiones Roche 1976

    Google Scholar 

  12. Schwab, R. S.: Progression and prognosis in Parkinson's disease. J. nerv. ment. Dis. 130, 556–566 (1960)

    Google Scholar 

  13. Sweet, R. D., McDowell, F. H.: Five years treatment of Parkinson's disease with levodopa. Ann. Intern. Med. 83, 456–463 (1975)

    Google Scholar 

  14. Yahr, M. D.: Levodopa. Ann. Intern. Med. 83, 677–682 (1975)

    Google Scholar 

  15. Yahr, M. D., Duvoisin, R. C., Schear, M. J., Barret, R. E., Hoehn, M. M.: Treatment of parkinsonism with levodopa. Arch. Neurol. 21, 343–354 (1969)

    Google Scholar 

  16. Zumstein, H., Siegfried, J.: Mortality among Parkinson patients treated with L-dopa combined with a decarboxylase inhibitor. Europ. Neurol. 14, 321–327 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marttila, R.J., Rinne, U.K., Siirtola, T. et al. Mortality of patients with parkinson's disease treated with levodopa. J. Neurol. 216, 147–153 (1977). https://doi.org/10.1007/BF00313615

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00313615

Key words

Navigation